25081-39-4

Basic information

• Product Name: METHYL 3,5-DIMETHYLBENZOATE
• Synonyms: METHYL 3,5-DIMETHYLBENZOATE;3,5-DIMETHYLBENZOIC ACID METHYL ESTER;RARECHEM AL BF 0341;Benzoic acid, 3,5-dimethyl-, methyl ester;3,5-Dimethylbenzoic acid methyl;Methyl 3,5-dimethylbenzoate 98%
• CAS NO: 25081-39-4
• Molecular Formula: C₁₀H₁₂O₂
• Molecular Weight: 164.2
• Product Categories: Aromatic Esters;C10 to C11;Carbonyl Compounds;Esters
• Mol File: 25081-39-4.mol
• Article Data: 28

Chemical Properties

• Melting Point: 31-33 °C(lit.)
• Boiling Point: 239-240 °C(lit.)
• Flash Point: 224 °F
• Appearance: /
• Density: 1.027 g/mL at 25 °C(lit.)
• Vapor Pressure: 0.033mmHg at 25°C
• Refractive Index: 1.5160 (estimate)
• Storage Temp.: Room temperature.
• CAS DataBase Reference: METHYL 3,5-DIMETHYLBENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 3,5-DIMETHYLBENZOATE(25081-39-4)
• EPA Substance Registry System: METHYL 3,5-DIMETHYLBENZOATE(25081-39-4)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 25081-39-4(Hazardous Substances Data)

Usage

Uses

Methyl 3,5-dimethylbenzoate may be used in the preparation of four carbon isostere related to highly active 4-pyridinemethanols, which were subsequently evaluated for their antimalarial activity. It may be used in the total synthesis of (±)-indoxamycin B.

General Description

Methyl 3,5-dimethylbenzoate is an aromatic carboxylic acid ester. It was selected as ligand during monomer screening for the synthesis and investigation of various europium compounds containing pinacolyl methylphosphonate with different ligands. Methyl 3,5-dimethylbenzoate is reported as precursor of methyl-3,5-divinylbenzoate.

InChI:InChI=1/C10H12O2/c1-7-4-8(2)6-9(5-7)10(11)12-3/h4-6H,1-3H3

Upstream product

• 67-56-1 methanol 
• 6613-44-1 3,5-dimethylbenzoyl chloride 
• 556-96-7 5-bromo-1,3-xylene 
• 22445-41-6 3,5-dimethylphenyl iodide 
• 929626-17-5 methyl 3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate 
• 74-88-4 methyl iodide 
• 512-56-1 trimethyl phosphite 
• 80-48-8 methyl p-toluene sulfonate 
• 51329-15-8 methyl 3,5-dibromobenzoate 
• 108-67-8 1,3,5-trimethyl-benzene 
• 5779-95-3 3,5-dimethylbenzaldehyde 
• 4919-37-3 3,5-dimethyl-4-hydroxybenzoic acid 
• 4749-37-5 3-nitroacrylic acid methyl ester 
• 186581-53-3 diazomethane 

Downstream Products

• 217192-36-4 (R)-3-(3,5-Dimethyl-benzoyl)-4-methyl-dihydro-furan-2-one 
• 223449-25-0 5-methoxycarbonyl-m-xylylene bisphosphonic acid tetramethyl ester 
• 105995-42-4 3,5-bis(aminomethyl)benzoic acid methyl ester 
• 376364-28-2 (S)-4-chloro-1-(3,5-dimethylphenyl)-3-methylbutan-1-one 
• 217192-38-6 (R)-4-chloro-1-(3,5-dimethylphenyl)-3-methylbutan-1-one 
• 367927-29-5 3,5-bis-(dimethoxyphosphorylmethyl)benzoic acid diethoxyphosphorylmethylamide 
• 75594-35-3 methyl 3,5-bis(methyltriphenylphosphonio)benzoate dibromide 
• 318267-12-8 {3,5-Bis-[(E)-2-(4',5'-bis-dodecylsulfanyl-[2,2']bi[[1,3]dithiolylidene]-4-yl)-vinyl]-phenyl}-methanol 
• 318267-11-7 3,5-Bis-[(E)-2-(4',5'-bis-dodecylsulfanyl-[2,2']bi[[1,3]dithiolylidene]-4-yl)-vinyl]-benzoic acid methyl ester 
• 120511-79-7 3-bromomethyl-5-methyl-benzoic acid methyl ester 
• 62034-72-4 N-hydroxy-3,5-dimethylbenzamide 
• 108-69-0 3,5-dimethylaminoaniline 
• 1046342-51-1 methyl 3,5-bis[(acetylsulfanyl)methyl]benzoate 
• 29232-73-3 3,5-bis-cyanomethyl-benzoic acid methyl ester 

Relevant articles and documents

Triazacyclophane (TAC)-scaffolded histidine and aspartic acid residues as mimics of non-heme metalloenzyme active sites

We describe the synthesis and coordination behaviour to copper(ii) of two close structural triazacyclophane-based mimics of two often encountered aspartic acid and histidine containing metalloenzyme active sites. Coordination of these mimics to copper(i)

GLUCOSE SENSITIVE INSULIN DERIVATIVES

The present invention relates to novel insulin derivatives and their use in the treatment or prevention of medical conditions relating to diabetes. The insulin derivatives are glucose sensitive and display glucose-sensitive albumin binding. The invention

GLUCOSE-SENSITIVE ALBUMIN-BINDING DERIVATIVES

This invention relates to glucose-sensitive albumin-binding diboron conjugates. More particularly the invention provides novel diboron compounds, and in particular diboronate or diboroxole compounds, useful as intermediate compounds for the synthesis of diboron conjugates. The diboron compounds are characterized by formula (I), which is: R1-X-R2, and wherein "X" is a mono- to multiatomic linker and where R1 and R2, which may be identical or different, each represents a group of Formula (lla) or (IIb) Also described are diboron conjugates represented by the general Formula (I'), which is: R1'-X'-R2', in which either the moeities R1' or R2' or X' carry a drug that is covalently attached to the diboron compound.